*仅供医学专业人士阅读参考
超过1/3的糖尿病患者合并CKD,但是随着肾脏功能丢失,患者用药逐渐受限,如何因“病”制宜地为患者选择降糖方案呢?
阅读全文,文末找答案。
[2]Zhang L, et al. Lancet. 2012;378(8878):815-822.
[3]Kaifeng Guo, et al. J Diabetes Complications. 2016;30(5):803-10.
[4]中华医学会肾脏病学分会专家组. 中华肾脏病杂志. 2021;37(3):255-304.
[5]Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney Int. 2020;98(4S):S1-S115.
[6]Luk AO, et al. Diabet Med. Diabet Med. 2016;33(9):1230-9.
[7]2018 USRDS Annual Data Report.
[8]Zoungas S, et al. Diabetologia 2012;55(3):636–643.
[9]Moen MF, et al. Clin J Am Soc Nephrol. 2009;4:1121–1127.
[10]Alsahli M and Gerich JE. Mayo Clin Proc. 2014;89:1564–71.
[11]Yu TM, et al. Neurology. 2014;83(8):686-94.
[12]UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
[13]Wong MG, et al. Diabetes Care. 2016;39(5):694 ?700.
[14]Alsahli M and Gerich JE. J Clin Med. 2015;4:948–64
[15]Harris S, et al. Presented at the 79th Scientific Sessions of the American Diabetes Association 2019;June 7–11; San Francisco, CA, US. 1095-P
[16]Bramlage P, et al. Cardiovasc Diabetol. 2019;18:33.
[17]Hong T, et al. Diabetes Ther. 2019;10(3):1051-1066.
[18]冉兴无, 等. 中国糖尿病杂志. 2020;10:721-728.
[19]Owens DR. Expert Opin Drug Metab Toxicol. 2016;12(8):977-87.
[20]Jonassen Ib, et al. Pharm Res. 2012;29(8):2104-2114.
[21]Kawaguchi Y, et al. Diabetes Ther. 2019;10(4):1535-1541.
[22]Cheng A, et al. Presented at the International Diabetes Federation Congress. 2019; December 2–6; Busnan, Korea. OP-0081.
[23]Julio Rosenstock, et al. Diabetes Care. 2018;41(10):2147-2154.
[24]Yale J, et al. Can J Diabetes. 2017;41(5):478-484.
文章来源:《糖尿病天地(临床)》 网址: http://www.tnbtd.cn/zonghexinwen/2021/0429/1153.html
糖尿病天地(临床)投稿 | 糖尿病天地(临床)编辑部| 糖尿病天地(临床)版面费 | 糖尿病天地(临床)论文发表 | 糖尿病天地(临床)最新目录
Copyright © 2018 《糖尿病天地(临床)》杂志社 版权所有
投稿电话: 投稿邮箱: